GeoVax preclinical data show durable single-dose MVA protection
GeoVax says its next-generation MVA vaccine demonstrated durable single-dose protection in preclinical models, including protection against highly pathogenic Clade I mpox virus.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
GeoVax says its next-generation MVA vaccine demonstrated durable single-dose protection in preclinical models, including protection against highly pathogenic Clade I mpox virus.